As of Apr 20
| -0.58 / -3.19%|
The 6 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 30.00, with a high estimate of 32.00 and a low estimate of 6.00. The median estimate represents a +70.55% increase from the last price of 17.59.
The current consensus among 6 polled investment analysts is to Buy stock in Corcept Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.